Form 4 Tracker
Carsten Boess

Director · 3 filings · Latest: Jun 18, 2026

Atrium Therapeutics, Inc.
Avidity Biosciences, Inc.
ROCKET PHARMACEUTICALS, INC.
TickerOwnerRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Filing
BOESS CARSTENFeb 4, 2025
Proposed Sale
$1.3625,000$34.0K